Severe anaphylaxis to royal jelly attributed to cefonicid.
Testi
S
S
Allergy and Clinical Immunology Unit, Azienda Sanitaria di Firenze, Florence, Italy. sergio.testi@asf.toscana.it
Cecchi
L
L
Severino
M
M
Manfredi
M
M
Ermini
G
G
Macchia
D
D
Capretti
S
S
Campi
P
P
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced / Q000175:diagnosis*; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy; D015790:Cefonicid / Q000009:adverse effects; D000529:Complementary Therapies / Q000009:adverse effects; D003951:Diagnostic Errors; D019587:Dietary Supplements / Q000009:adverse effects*; D005227:Fatty Acids / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D008297:Male; D012882:Skin Tests; D000099219:Royal Jelly
D000900:Anti-Bacterial Agents; D015790:Cefonicid; D005227:Fatty Acids; D000099219:Royal Jelly